Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura

Autor: Flora Peyvandi, Marie Scully, J. A. Kremer Hovinga, Katerina Pavenski, J de la Rubia, J. Minkue Mi Edou, Paul Knoebl, Leylagül Kaynar, R. De Passos Sousa, Spero R. Cataland, Filip Callewaert, Paul Coppo

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 62-63 (2020)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c9e79f73d17d560085f5d6ec6e3172
https://doi.org/10.1016/j.htct.2020.09.112

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis.

Autor: Peyvandi F; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Cataland S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Scully M; Department of Haematology, University College London Hospital National Health Service Trust, London, United Kingdom., Coppo P; Department of Hematology, Reference Center for Thrombotic Microangiopathies, Saint-Antoine University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France., Knoebl P; Department of Medicine 1, Division of Hematology and Hemostasis, Medical University of Vienna, Vienna, Austria., Kremer Hovinga JA; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Metjian A; Department of Medicine, Duke University School of Medicine, Durham, NC., de la Rubia J; Hematology Department, Internal Medicine, School of Medicine and Dentistry, Catholic University of Valencia and Hospital Doctor Peset, Valencia, Spain., Pavenski K; Departments of Laboratory Medicine and Medicine, St. Michael's Hospital, Toronto, Canada.; Departments of Laboratory Medicine and Pathobiology and Medicine, University of Toronto, Toronto, Canada., Minkue Mi Edou J; Clinical Development, Ablynx, a Sanofi company, Ghent, Belgium; and., De Winter H; Clinical Development, Ablynx, a Sanofi company, Ghent, Belgium; and., Callewaert F; Medical Affairs, Sanofi, Diegem, Belgium.

Publikováno v: Blood advances [Blood Adv] 2021 Apr 27; Vol. 5 (8), pp. 2137-2141.